Overview of Dr. Leitao
Dr. Mario Leitao is an obstetrician/gynecologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan-Kettering Cancer Center and Memorial Hospital for Cancer and allied Diseases. He received his medical degree from Rutgers Robert Wood Johnson Medical School and has been in practice 21 years. Dr. Leitao accepts several types of health insurance, listed below. He is one of 32 doctors at Memorial Sloan-Kettering Cancer Center and one of 4 doctors at Memorial Hospital for Cancer and allied Diseases who specialize in Obstetrics & Gynecology. He has more than 100 publications and over 500 citings.
Education & Training
Memorial Sloan Kettering Cancer CenterResidency, Gynecologic Oncology, 2000 - 2004
Icahn School of Medicine at Mount Sinai (Beth Israel)Residency, Obstetrics and Gynecology, 1996 - 2000
Rutgers Robert Wood Johnson Medical SchoolClass of 1996
Certifications & Licensure
NJ State Medical License 2004 - 2025
NY State Medical License 1997 - 2024
FL State Medical License 2018 - 2020
- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- Fellow (FACS) American College of Surgeons
Clinical Trials
- Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer Start of enrollment: 2007 Dec 06
Active, not recruiting
Phase 3
- Lymphedema After Surgery in Patients With Endometrial Cancer, Cervical Cancer, or Vulvar Cancer Start of enrollment: 2012 Jun 01
Unknown status
Not Applicable
- Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors Start of enrollment: 2010 Feb 08
Active, not recruiting
Phase 2
- Join now to see all
Publications & Presentations
PubMed
Uterine transposition: a simple yet revolutionary means of fertility preservation for women with cancer.
Mario Leitao> ;International Journal of Gynecological Cancer. 2023 Dec 4Assessing the Genomic Landscape of Cervical Cancers: Clinical Opportunities and Therapeutic Targets.
Claire F Friedman, Vignesh Ravichandran, Kathryn Miller, Chad Vanderbilt, Qin Zhou, Alexia Iasonos, Malavika Vivek, Pamela Mishra, Mario M Leitao Jr, Vance Broach, Yuk...> ;Clinical Cancer Research. 2023 Nov 14Correspondence on "ESGO/ESTRO/ESP guidelines for the management of patients with cervical cancer: update 2023" by Cibula.
Andreas Obermair, Mario Leitao> ;International Journal of Gynecological Cancer. 2023 Jul 3- Join now to see all
Journal Articles
Impact of Hospital Volume on Surgical Management and Outcomes for Early-Stage Cervical Cancer
Mario Leitao Jr., MD, Gynecologic OncologyMinimally Invasive Surgery Versus Laparotomy for Radical Hysterectomy in the Management of Early-Stage Cervical Cancer: Survival Outcomes
Mario Leitao Jr., MD, Gynecologic Oncology
Press Mentions
The 6th Biennial Meeting of the Asian Society of Gynecologic Oncology, October 10th to 12th, 2019July 3rd, 2020
Same Outcomes Found for Conventional and Computer-Aided Knee-Replacement SurgeryNovember 26th, 2012
Professional Memberships
Hospital Affiliations
Insurance Accepted
Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
BCBS Illinois PPO
BCBS Minnesota Blue Cross Accord
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Empire BCBS HMO
Empire BCBS PPO
First Health PPO
GHI PPOGreat West PPO
Humana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PPO
MVP Healthcare PPO
Oxford Health Freedom
Oxford Health Liberty
QualCare HMO
QualCare PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO
WEA Trust Preferred Provider Plan - Trust Pref- Please verify your coverage with the provider's office directly when scheduling an appointment